Contineum Therapeutics (CTNM) Institutional Ownership $4.61 +0.04 (+0.88%) As of 02:57 PM Eastern Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Contineum Therapeutics (NASDAQ:CTNM)Number ofInstitutional Buyers(last 12 months)37TotalInstitutional Inflows(last 12 months)$130.88MNumber ofInstitutional Sellers(last 12 months)8TotalInstitutional Outflows(last 12 months)$12.42M Get CTNM Insider Trade Alerts Want to know when executives and insiders are buying or selling Contineum Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CTNM Institutional Buying and Selling by Quarter Contineum Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/28/2025 Strs Ohio3,900$27K0.0%N/A0.015% 5/16/2025 Goldman Sachs Group Inc.14,221$99K0.0%-46.1%0.055% 5/16/2025 Dynamic Technology Lab Private Ltd16,838$118K0.0%N/A0.065% 5/16/2025 ADAR1 Capital Management LLC168,765$1.18M0.2%+105.2%0.652% 5/13/2025 Altium Capital Management LLC303,857$2.12M5.1%-9.0%1.174% 5/12/2025 Nuveen LLC13,307$93K0.0%N/A0.051% 5/9/2025 Charles Schwab Investment Management Inc.51,202$357K0.0%-7.5%0.198% 2/17/2025 Squarepoint Ops LLC217,239$3.18M0.0%-37.9%0.843% 2/17/2025 Stempoint Capital LP265,833$3.89M1.0%N/A1.031% 2/17/2025 Red Tree Management LLC638,158$9.35M6.2%N/A2.475% Get the Latest News and Ratings for CTNM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Contineum Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/17/2025 Polar Capital Holdings Plc43,604$639K0.0%-79.9%0.169% 2/17/2025Nuveen Asset Management LLC13,307$195K0.0%N/A0.052% 2/17/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.5,860$86K0.0%+90.4%0.023% 2/17/2025 Janus Henderson Group PLC68,320$1.00M0.0%N/A0.265% 2/17/2025 Deutsche Bank AG16,079$236K0.0%N/A0.062% 2/17/2025 Bank of America Corp DE9,132$134K0.0%+63.4%0.035% 2/14/2025 Schonfeld Strategic Advisors LLC125,995$1.85M0.0%N/A0.489% 2/14/2025 Northern Trust Corp89,262$1.31M0.0%+42.3%0.346% 2/14/2025 MetLife Investment Management LLC7,029$103K0.0%N/A0.027% 2/14/2025 Altium Capital Management LLC334,000$4.89M1.4%-9.5%1.296% 2/13/2025 Marshall Wace LLP10,836$159K0.0%N/A0.042% 2/13/2025 Strategies Wealth Advisors LLC25,000$366K0.0%N/A0.097% 2/13/2025 Barclays PLC16,286$239K0.0%+96.0%0.063% 2/13/2025 Legal & General Group Plc3,631$53K0.0%+74.0%0.014% 2/13/2025 ADAR1 Capital Management LLC82,234$1.21M0.2%+817.1%0.319% 2/13/2025 Wells Fargo & Company MN10,755$158K0.0%+419.3%0.042% 2/12/2025 Geode Capital Management LLC188,408$2.76M0.0%+46.4%0.731% 2/12/2025 Franklin Resources Inc.1,445,565$21.18M0.0%-0.1%5.607% 2/12/2025 Norges Bank169,729$2.49M0.0%N/A0.658% 2/12/2025 JPMorgan Chase & Co.28,426$416K0.0%+1,040.7%0.110% 2/12/2025 WINTON GROUP Ltd39,738$582K0.0%+256.8%0.154% 2/11/2025 Corebridge Financial Inc.5,215$76K0.0%+73.1%0.020% 2/6/2025 Charles Schwab Investment Management Inc.55,330$811K0.0%+27.8%0.215% 2/4/2025 Bank of New York Mellon Corp18,738$275K0.0%+32.3%0.073% 1/30/2025 Rhumbline Advisers8,233$121K0.0%+36.3%0.032% 11/27/2024 Franklin Resources Inc.1,447,550$27.71M0.0%+130.9%5.615% 11/19/2024 Barclays PLC8,308$158K0.0%+248.6%0.032% 11/16/2024 Geode Capital Management LLC128,676$2.46M0.0%-17.7%0.500% 11/15/2024 Barclays PLC8,308$158K0.0%+248.6%0.032% 11/15/2024 State Street Corp113,566$2.17M0.0%+23.7%0.442% Is Elon's empire crumbling? (Ad)The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as July 23rd. Click here to see the Tesla shock that could blindside everyone.11/14/2024 Suvretta Capital Management LLC1,720,000$32.92M1.1%-16.2%6.687% 11/13/2024 BNP Paribas Financial Markets6,743$129K0.0%+1,248.6%0.026% 11/13/2024 FMR LLC696,927$13.34M0.0%+115.4%2.710% 11/12/2024 Charles Schwab Investment Management Inc.43,295$829K0.0%-16.4%0.168% 8/16/2024 Perceptive Advisors LLC1,566,668$27.59M0.7%N/A6.091% 8/16/2024 Driehaus Capital Management LLC66,667$1.17M0.0%N/A0.259% 8/14/2024 Squarepoint Ops LLC150,000$2.64M0.0%N/A0.583% 8/14/2024 Sandia Investment Management LP5,000$88K0.1%N/A0.019% 8/9/2024 Johnson & Johnson1,979,173$34.85M8.7%N/A7.694% 8/8/2024 Versant Venture Management LLC918,163$16.17M20.9%N/A3.569% 8/1/2024 Rhumbline Advisers6,722$118K0.0%N/A0.026% 7/26/2024 Bank of New York Mellon Corp20,232$356K0.0%N/A0.079% (Data available from 1/1/2016 forward) CTNM Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CTNM shares? During the previous two years, 41 institutional investors and hedge funds held shares of Contineum Therapeutics. The most heavily invested institutionals were Johnson & Johnson ($34.85M), Suvretta Capital Management LLC ($32.92M), Perceptive Advisors LLC ($27.59M), Franklin Resources Inc. ($21.18M), Versant Venture Management LLC ($16.17M), FMR LLC ($13.34M), and Red Tree Management LLC ($9.35M).Learn more on CTNM's institutional investors. Which institutional investors have been buying Contineum Therapeutics stock? Of the 37 institutional investors that purchased Contineum Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Johnson & Johnson ($1.98M), Perceptive Advisors LLC ($1.57M), Versant Venture Management LLC ($918.16K), Franklin Resources Inc. ($820.54K), Red Tree Management LLC ($638.16K), FMR LLC ($373.33K), and Stempoint Capital LP ($265.83K). How much institutional buying is happening at Contineum Therapeutics? Institutional investors have bought a total of 7,666,821 shares in the last 24 months. This purchase volume represents approximately $130.88M in transactions. Which Contineum Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Contineum Therapeutics stock in the last 24 months: Suvretta Capital Management LLC ($333.33K), Polar Capital Holdings Plc ($173.00K), Squarepoint Ops LLC ($132.76K), Altium Capital Management LLC ($65.27K), Geode Capital Management LLC ($27.75K), Charles Schwab Investment Management Inc. ($12.61K), and Goldman Sachs Group Inc. ($12.14K). How much institutional selling is happening at Contineum Therapeutics? Institutional investors have sold a total of 758,840 shares in the last 24 months. This volume of shares sold represents approximately $12.42M in transactions. Related Companies AMLX Institutional Ownership PRTC Institutional Ownership SEPN Institutional Ownership ORKA Institutional Ownership TRML Institutional Ownership MBX Institutional Ownership SIGA Institutional Ownership UPXI Institutional Ownership ALT Institutional Ownership TECX Institutional Ownership This page (NASDAQ:CTNM) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGet Ready for Elon Musk’s BIGGEST Comeback YetTesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Contineum Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Contineum Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CTNM Stock Free CTNM Stock Alerts